Key finding: AOD-9604 failed to produce statistically significant weight loss compared to placebo in a clinical trial
All tests are processed through accredited UK labs, and results are interpreted to help guide peptide selection or dosing for those conducting experimental or educational research
Scientific Research (1) Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ
[Epub ahead of print] The Safety and Efficacy of LowDose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohns Disease, and Other Chronic Pain Disorders
It is often used to manage nausea and vomiting during pregnancy under medical supervision